Article

Are X-rays Overused in the Intensive Care Setting?

Study results presented at CHEST 2013 show that the use of ultrasound testing rather than x-rays or CT scans in the ICU reduces patient radiation exposure and lowers costs of care.

(Chicago, Illinois) October 28, 2013—A new study shows that the use of ultrasound testing rather than x-rays or CT scans in the ICU reduces patient radiation exposure and lowers costs of care. The study was presented at CHEST 2013, the annual meeting of the American College of Chest Physicians (ACCP).

“We found that the use of ultrasound to diagnose patients greatly reduced radiation exposure for patients without negatively affecting their health,” said Margarita Oks, MD, Long Island Jewish Hospital, North Shore-LIJ Health System. “It was also cost-effective.”

Ultrasound, also called sonography, is an imaging method that uses high-frequency sound waves to produce images that lead to diagnosis and treatment of many diseases and medical conditions. Radiation is not used in ultrasound testing, but is used in x-rays and CT scans.

Dr. Oks and her colleagues studied medical charts covering 3 months of data comparing chest x-rays, CT scans, and ultrasound between two independent but similar medical intensive care units staffed by the same medical house staff in one health-care system. One unit used bedside ultrasound as the standard of care for diagnosis; the second used conventional imaging, such as x-rays and CT scans, as its standard of care in diagnosis.

Researchers found that there were 5.21 x-rays done per patient stay in the ICU using x-rays and CT scans, while there were 1.10 x-rays per patient stay in the unit using ultrasound as the standard of care. Total CT scans were 0.91 in the nonultrasound ICU vs 0.26 per patient stay in the ultrasound unit. There were 0.27 cardiac echocardiograms in the nonultrasound ICU vs 0.11 in the ultrasound ICU per patient stay. Mortality rates did not differ greatly, with 0.27 in the nonultrasound ICU vs 0.20 in the ultrasound ICU.

Source: American College of Chest Physicians

Related Videos
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
What to Look Forward To at the Fall Clinical Dermatology Conference, with Raj Chovatiya, MD, PhD
Christine N. Kay, MD: Interim Data on ATSN-201 Shows Promise for XLRS | Image Credit: Vitreo Retinal Associates
Arshad Khanani, MD: First Results from Fellow Eye Dosing of RGX-314 in nAMD | Image Credit: Sierra Eye Associates
Jonathan Barratt, MD | Credit: IgA Nephropathy Foundation
© 2024 MJH Life Sciences

All rights reserved.